Design and Synthesis of 3-Hydroxy-pyridin-4(1 H )-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa .
Yuan-Yuan WangXiao-Yi ZhangXiao-Lin ZhongYong-Jun HuangJing LinWei-Min ChenPublished in: Journal of medicinal chemistry (2023)
Pseudomonas aeruginosa infections are often complicated by the fact that it can easily form a biofilm that increases its resistance to antibiotics. Consequently, the development of novel antibacterial agents against biofilm-associated drug-resistant P. aeruginosa is urgently needed. Herein, we report a series of 3-hydroxy-pyridin-4(1 H )-ones-ciprofloxacin conjugates that were designed and synthesized as dual antibacterial and antibiofilm agents against P. aeruginosa . A potential 2-substituted 3-hydroxy-1,6-dimethylpyridin-4(1 H )-one-ciprofloxacin conjugate ( 5e ) was identified and had the best minimum inhibitory concentrations of 0.86 and 0.43 μM against P. aeruginosa 27853 and PAO1 and reduced 78.3% of biofilm formation. In addition, 5e eradicates mature biofilms and kills living bacterial cells that are incorporated into the biofilm. Studies on the antibiofilm mechanism of conjugates showed that 5e interferes with iron uptake by bacteria, inhibits their motility, and reduces the production of virulence. These results demonstrate that 3-hydroxy-pyridin-4(1 H )-ones-ciprofloxacin conjugates are potent in the treatment of biofilm-associated drug-resistant P. aeruginosa infections.
Keyphrases
- pseudomonas aeruginosa
- drug resistant
- biofilm formation
- acinetobacter baumannii
- multidrug resistant
- cystic fibrosis
- cancer therapy
- silver nanoparticles
- anti inflammatory
- candida albicans
- induced apoptosis
- staphylococcus aureus
- cell cycle arrest
- drug delivery
- essential oil
- escherichia coli
- cell death
- risk assessment
- climate change
- oxidative stress
- combination therapy